Table 1. Clinical characteristics of patients whose vitreous samples were used for protein analysis with antibody arrays.

Case	Status1	Ophthalmological Status	Age	Sex	Hemorrhage2	Degree of Fibrosis3	Degree of Neovascularisation4	Laser	Avastin	Array5
1	CON	Vitreal floaters	61	F	0	0	0	no	no	L+Q
2	CON	Vitreal floaters	59	F	0	0	0	no	no	L+Q
3	CON	Vitreal floaters	42	M	0	0	0	no	no	L+Q
4	CON	Vitreal floaters	51	F	0	0	0	no	no	Q
5	CON	Vitreal floaters	49	F	0	0	0	no	no	Q
6	CON	Vitreal floaters	68	M	0	0	0	no	no	L+Q
7	CON	Vitreal floaters	73	F	0	0	0	no	no	L+Q
8	DM2	PDR withoutFVM	54	F	1	0	0	yes	no	Q
9	DM2	PDR with FVM	44	M	3	3	2	yes	no	L+Q
10	DM2	PDR without FVM6	62	F	0	0	0	yes	yes	Q
11	DM2	PDR with FVM	56	M	2	2	2	yes	yes	L+Q
12	DM2	PDR with FVM	54	M	2	2	0	yes	no	Q
13	DM2	PDR with FVM	59	F	0	3	1	yes	yes	Q
14	DM2	PDR without FVM	63	M	1	0	2	yes	yes	Q
15	DM2	PDR without FVM	67	M	3	0	1	yes	no	Q
16	DM2	PDR with FVM	27	M	1	3	2	yes	yes	L
17	DM2	PDR with FVM	35	F	1	3	2	yes	yes	L
18	DM2 + INS	PDR with FVM	55	F	2	2	1	yes	no	Q
19	DM2 + INS	PDR with FVM	48	F	2	3	2	no	yes	L+Q
20	DM2 + INS	PDR with FVM	53	F	0	3	2	yes	no	L+Q
21	DM2 + INS	PDR without FVM	51	M	3	0	2	yes	no	Q
22	DM2 + INS	PDR with FVM	51	F	1	2	2	yes	yes	Q
23	DM2 + INS	PDR with FVM	57	M	0	3	2	no	yes	L

¹ Diabetic status: CON, no diabetes; DM2, diabetes type 2; DM2 + INS, diabetes type 2 with insulin dependency.

² Hemorrhage: 0, no hemorrhage; 1, mild hemorrhage; 2, moderate hemorrhage or heavy hemorrhage more than 2 months ago; 3, heavy hemorrhage within 2 months.

³ Degree of fibrosis: 0, no evidence of fibrosis; 1, few pre-retinal membranes; 2, membranes with limited extension into the vitreous; 3, abundant white membranes reaching into the vitreous body.

⁴ Degree of neovascularisation: 0, absent; 1, quiescent; 2, active.

⁵ Array used: L, L507 Array; Q, Quantibody Array.

⁶ Patient was operated for vitreomacular traction